Immunoloregulation effect of microcapsulated catechin on a mouse model of cyclophosphamide-induced hypoimmunity
Shi-you Peng,Xiao-jie He,Zhu-wen Yi,Zi-chuan Xu,Xi-qiang Dang,Hua-bin Yang
DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.21.028
2009-01-01
Abstract:BACKGROUND: It is well known that catechin has a strong antioxygeri activity; however, there are few reports about immunoloregulation. In addition, catechin is limited by instability and poor liposolubility. Microencapsulation is an effective way to solve the problems mentioned above. OBJECTIVE: To compare the effect of microcapsulated catechin and single catechin on specific cellular immunity, specific humoral immunity, non-specific humoral immunity, and organ coefficient of thymus and spleen in a mouse model of cyclophosphamide-induced hypoimmunity. DESIGN, TIME AND SETTING: A randomized controlled animal study was performed at Medical Experimental Animal Center, the Second Xiangya Hospital of Central South University from November to December 2007. MATERIALS: Catechin was provided by Jinnong Biotic Resource Co., Ltd., Hunan; microcapsulated catechin was provided by Institute of Pediatric Renal Disease, the Second Xiangya Hospital of Central South University; cyclophosphamide was provided by Hualian Pharmaceutical Co., Ltd., Shanghai. METHODS: A total of 600 Kunming mice were randomly divided into saline group, catechin (500, 250, 125 mg/kg) groups, ethyl cellulose (500, 250, 125 mg/kg) groups, microcapsulated catechin (500, 250, 125 mg/kg) groups, cyclophosphamide group, cyclophosphamide + microcapsulated catechin (500, 250, 125 mg/kg) groups, cyclophosphamide + catechin (500, 250, 125 mg/kg) groups, and cyclophosphamide + ethyl cellulose (500, 250, 125 mg/kg) groups. Saline, catechin, ethyl cellulose, and microcapsulated catechin were perfused respectively for 14 successive days; cyclophosphamide (80 mg/kg) was intraperitoneally injected from the 11 th day for 4 successive days. MAIN OUTCOME MEASURES: Specific cellular immune function was detected using delayed hypersensitivity; specific humoral immune function was measured using serum-hemolysin test; non-specific humoral immune function and organ coefficient of spleen and thymus were detected using carbon expurgatory index. RESULTS: Compared to saline group, ear swelling was increased in microcapsulated catechin group and single catechin (500, 250 mg/kg) groups. Serum hemolysin level (HC 50), carbon expurgatory index, phagocytic index, spleen index, and thymus index were significantly increased in the microcapsulated catechin (500, 250, 125 mg/kg) groups (P < 0.01, P < 0.05). HC 50 was increased to a certain degree in the catechin (500 mg/kg) group, and carbon expurgatory index, phagocytic index, spleen index and thymus index were significantly increased in the catechin (500, 250, 125 mg/kg) groups (P < 0.05, P < 0.01). Compared to cyclophosphamide group, ear swelling, HC 50, carbon expurgatory index, phagocytic index, spleen index, and thymus index were significantly increased in the cyclophosphamide + catechin (500, 250 mg/kg) groups and cyclophosphamide + microcapsulated catechin (500, 250 mg/kg) groups (P < 0.05, P < 0.01). Ear swelling, HD 50, spleen index, thymus index, carbon expurgatory index, and phagocytic index in the microcapsulated catechin groups were higher than single catechin groups. CONCLUSION: Catechin can improve specific cellular immunity, specific humoral Immunity, non-specific humoral immunity, and organ coefficient of spleen and thymus in a mouse model of cyclophosphamide-induced hypoimmunity. Furthermore, the effect of microcapsulated catechin is superior to single catechin.